The Anthrax Vaccine Program: An Analysis of the CDC's
American Journal of Public Health 2002 May; 92(5): 715-721
The anthrax vaccine was never proved to be safe and effective. It is one cause of Gulf War illnesses, and recent vaccinees report symptoms resembling Gulf War illnesses. The vaccine's production has been substandard. Without adequate evaluation, the Food and Drug Administration recently approved (retrospectively) significant changes made to the vaccine's composition since 1990. The vaccine's mandatory use for inhalation anthrax is "off-label." A skewed review of the vaccine literature by the Centers for Disease Control and Prevention (CDC) led to remunerative collaborative research with the army, involving civilian volunteers. Despite acknowledging possible fetal harm, the CDC offered the vaccine to children and pregnant women. New trends could weaken prelicensure efficacy and safety review of medical products intended for biodefense and avoid manufacturer liability for their use.
Showing items related by title, author, creator and subject.
A Bill to Suspend Further Implementation of the Department of Defense Anthrax Vaccination Program Until the Vaccine Is Determined to Be Safe and Effective and to Provide for a Study by the National Institutes of Health of That Vaccine Unknown author (United States. Congress. House, 1999-07-19)
The Impact of the Anthrax Vaccine Program on Reserve and National Guard Units. Hearing Before the Subcommittee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform. U.S. House Of Representatives, 106th Congress, 1st Session. September 29, 1999. 128 P Unknown author (United States. Congress. House of Representatives. Committee on Government Reform. Subcommittee on National Security, Veterans Affairs, and International Relations, 2000)